Haemostaseological aspects of perioperative blood management;Hämostaseologische aspekte des perioperativen blutmanagements

Zentralblatt fur Chirurgie

Volumn 128, Issue 6, 2003, Pages 473-480

  Scherer, Ralf U ^a,b  

^a Evangelisches/Johanniter Klinikum   (Germany)

^b Klinikum Niederrhein gGmbH   (Germany)

Author keywords

Bleeding; Coagulation; Coagulation disorders; Coagulation factors; Perioperative blood management; Transfusion

Indexed keywords

ACTIVATED PROTEIN C; ANTISENSE OLIGONUCLEOTIDE; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING INHIBITOR; BLOOD SUBSTITUTE; CELL SURFACE PROTEIN; FRESH FROZEN PLASMA; GLYCOSAMINOGLYCAN; PROCOAGULANT; RECOMBINANT BLOOD CLOTTING FACTOR 7; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CELL SURFACE; CRITICAL ILLNESS; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; ERYTHROCYTE CONCENTRATE; FILTRATION; HEMOSTASIS; HUMAN; LABORATORY TEST; MONOCYTE; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; PROTEIN FUNCTION; REVIEW; SYMPTOM; THROMBOCYTE;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CONTROLLED CLINICAL TRIALS; CRITICAL ILLNESS; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; HEMOSTASIS; HUMANS; MICROCIRCULATION; PLATELET TRANSFUSION; SURGICAL PROCEDURES, OPERATIVE;

EID: 0043269380     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40620     Document Type: Review

References (53)

1. Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988; 85: 7462-7466
2. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D. Antibodies to macromolecular platelet factor 4 - heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemostas 1995; 73: 21-28
3. Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-4020
4. Bernstein D. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis. Semin Thromb Hemost 2000; 26: 437-438
5. Boldt J, Zickmann B, Ballesteros M, Oehmke S, Stertmann F, Hempelmann G. Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery. J Cardiothorac Vasc Anesth 1993; 7: 4-9
6. Canonico AE, Conary JT, Meyrick BO, Brigham KL. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 1994; 10: 24-29
7. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transscription of thrombomodulin gene in endothelial cells. Mol Cell Biol 1988; 8: 5588-5592
8. Dahlbäck B. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 1999; 25: 273-289
9. Edwards EL, Rickles FR. The role of leucocytes in the activation of blood coagulation. Semin Hematol 1992; 29: 202-212
10. 2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity. Prostaglandins 1980; 20: 1103-1109
11. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
12. Fielding RM. The use of inhaled liposome formulations for drug delivery to the lungs and systemic circulation. Proc West Pharmacol Soc 1989; 32: 103-106
13. Galvin JB, Kurosawa S, Moore K, Esmon CT, Esmon NL. Reconstitution of rabbit thrombomodulin into phospholipid vesicles. J Biol Chem 1987; 262: 2199-2205
14. Garry B, Lisman S, Wurm WH. Intraoperative reinfusion of whole blood using a new autoinfusion device. Can J Anaesth 1993; 40: 791-795
15. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-2755
16. Holmsen H. Biochemistry and function of platelets. Composition of platelets. In: Williams WJ, Beutler E, Erslëv AJ, Lichtman MA (Hrsg). Hematology. McGraw Hill, New York 1991; 1182-1200
17. Horie S, Ishii H, Kazama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III - dependent but not thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 1990; 59: 895-904
18. Howdieshell TR, Gay M, DiPiro JT, Mooney S, Duvall R, Eckles S, Baisden R. Heparin versus citrate regional anticoagulation during autotransfusion in a porcine intra-abdominal hemorrhage model. Am Surg 1997; 63: 1014-1018
19. Kashima I, Ueda T, Shimizu H, Mitsumaru A, Tsutsumi K, Iino Y, Enoki C, Koizumi K, Kawada S. Efficacy of autologous platelet-rich plasma in thoracic aortic aneurysm surgery. Jpn J Thorac Cardiovasc Surg 2000; 48: 708-712
20. Langer R. Drug delivery. Drugs on target. Science 2001; 293: 58-59
21. Lim TK, Bloomfield VA, Nelsestuen GL. Structure of the prothrombin- and blood clotting factor X-membrane complexes. Biochemistry 1977; 16: 4177-4181
22. Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29: 213-226
23. Marcum JA, McKenney JB, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 1984; 74: 341-345
24. Marcum JA, Rosenberg RD. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemost 1987; 13: 464-474
25. Menges T, Welters I, Wagner RM, Boldt J, Dapper F, Hempelmann G. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery. Eur J Cardiothorac Surg 1997; 11: 557-563
26. Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26: 373-377
27. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
28. Mortelmans Y, Vermaut G, Van Aken H, Goossens W, Boogaerts M. Quality of washed salvaged red blood cells during total hip replacement: a comparison between the use of heparin and citrate as anticoagulants. Anesth Analg 1994; 79: 357-363
29. Nakamura K, Okamoto M, Akioka K, Matsuyama M, Yoshimura R, Ushigome H, Kadotani Y, Ohmori Y, Yoshimura N. Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat. Transplant Proc 2001; 33: 3707-3708
30. Niewiarowski S, Thomas DP. Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature 1969; 222: 1269-1272
31. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
32. Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/re- perfusion. Circulation 1997; 96: 2302-2310
33. Prescott SM, Zimmermann GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990; 265: 17381-17384
34. Rosenberg RD, Bauer KA. Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S. Hum Pathol 1987; 18: 253-262
35. Rybak ME, Renzulli LA. A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. Biomater Artif Cells Immobilization Biotechnol 1993; 21: 101-118
36. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125
37. Scherer R, Kabatnik M, Erhard J, Peters J. The influence of antithrombin III substitution to supra-normal activities on systemic procoagu-lant turnover in patients with end-stage chronic liver disease. Intensive Care Med 1997; 23: 1150-1158
38. Scherer R, Paar D, Stöcker L, Kox W. Diagnose und Therapie pathologischer Gerinnungsaktivierungen. Anästhesist 1994; 43: 347-354
39. Scherer R, Pulletz S. Consequences of haemostasis disorders on anaesthetic management. Current Opinion in Anesthesiology 1999; 12: 349-352
40. 2) substitution on systemic procoagulant turnover and cardiorespiratory variables in experimental hypercoagulability. Haemostasis 1997; 27: 16-24
41. Scherer R. Anästhesiologie - ein handlungsorientiertes Lehrbuch. Thieme Verlag Stuttgart 2000; 1. Aufl: 151-152
42. Stephens AC, Rivers RP. Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide. Thromb Res 1997; 85: 387-398
43. Stern EM, Esposito C, Gerlach H, Gerlach M, Ryan J, Handley D, Nawroth P. Endothelium and regulation of coagulation. Diabetes Care 1991; 14: 160-166
44. Triulzi DJ, Gilmor GD, Ness PM, Baumgartner WA, Schultheis LW. Efficacy of autologous fresh whole blood or platelet-rich plasma in adult cardiac surgery. Transfusion 1995; 35: 627-634
45. Trubetskoy VS, Torchilin VP, Kennel S, Huang L. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(L-lysine)-antibody conjugate in mouse lung endothelial cells. Biochim Biophys Acta 1992; 1131: 311-313
46. Uchiba M, Okajima K. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. Semin Thromb Hemost 1997; 23: 583-590
47. Van't Veer C, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost 2000; 26: 367-372
48. Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36
49. Verstraete M, Zoldhelyi P. Novel antithrombotic drugs in development. Drugs 1995: 49: 856-884
50. Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567
51. 2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood 1979; 53: 244-249
52. Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989; 163: 1404-1411
53. Zur M, Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem 1980; 255: 5703-5707